Arizona Alzheimer's Disease Research Center (ADRC)

The Arizona Alzheimer's Disease Research Center (ADRC) is the National Institute on Aging's (NIA's) first statewide AD Center (ADC), the only ADC in the Southwestern United States, and a leading example of statewide collaboration in biomedical research. It capitalizes on Arizona's strengths in brain imaging, genomics, computer science and biomathematics, the basic, cognitive and behavioral neurosciences, clinical, and neuropathological studies of AD, the discovery and evaluation of investigational treatments, and the study of normal cognitive aging.

Recruiting

Interested in participating?

Request Info

Key information

Conditions

Alzheimer Disease Brain Diseases Central Nervous System Diseases Dementia Mental Disorders Nervous System Diseases Neurocognitive Disorders Neurodegenerative Diseases Tauopathies

Age range

40 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Banner Alzheimer's Institute, Phoenix, Arizona, United States

Who can participate

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Cognitively normal persons, individuals with mild cognitive impairment or dementia who are at least 40 years of age.
Willing to undergo health and cognitive assessments, and collection and banking of blood with venipuncture for genetic research, biomarker research, and DNA banking.

Exclusion criteria

1. Participants whose diagnosis is unclear and confounded by multiple possible factors are excluded. Participants with diagnoses of non-AD dementias are not excluded.

Participants whose primary diagnosis is cognitive impairment due to a penetrating or single severe closed head injury, multiple sclerosis, brain tumor, metabolic or toxic encephalopathy, post-infectious (e.g., viral encephalitis, bacterial meningitis), paraneoplastic, primary psychiatric illness, or otherwise not deemed relevant to the intent of the Alzheimer Disease Center program are excluded.

Procedure specific exclusion criteria also apply but this does not impact the participants ability to be included in the study.

Treatment and study plan

Primary outcomes

Cognitive Status

Time frame: 12 months

The ADRC uses a prospective, standardized, and longitudinal clinical evaluation of participants to determine their cognitive status. This includes tests that assess short and long term memory, ability to complete daily tasks, and processing of information.

Study contacts

Contact information is provided by the study sponsor or research team.

Trisha Walsh

CONTACT

[email protected]

602.839.6029

Sponsors and collaborators

Lead sponsor

Banner Health

Other

Registry information

Important dates

Study start: 2021
Primary completion: 2026
Study completion: 2026
First posted: Jun 6, 2022
Registry last updated: Aug 19, 2024

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Recruiting